The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6239-6245

  Gong, Hua Chang ^a   Honjo, Yuichiro ^a   Nangia Makker, Pratima ^a   Hogan, Victor ^a   Mazurak, Nachman ^c   Bresalier, Robert S ^c   Raz, Avraham ^a,b  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HENRY FORD HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALAPTIN; GALECTIN 3; GREEN FLUORESCENT PROTEIN; CASEIN KINASE; COMPLEMENTARY DNA; DIFFERENTIATION ANTIGEN; PEPTIDE FRAGMENT; PROTEIN KINASE; SERINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL COMPARTMENTALIZATION; CELL FUNCTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; TUMOR GROWTH; BINDING SITE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CELL TRANSFORMATION; GENE DELETION; GENETIC TRANSFECTION; GENETICS; HEMAGGLUTINATION; METABOLISM; NEOPLASM; PHOSPHORYLATION; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS; TRANSPORT AT THE CELLULAR LEVEL;

ANTIGENS, DIFFERENTIATION; BINDING SITES; BIOLOGICAL TRANSPORT; CASEIN KINASES; CELL COMPARTMENTATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DNA, COMPLEMENTARY; GALECTIN 3; GENE DELETION; HEMAGGLUTINATION; HUMANS; MUTAGENESIS, SITE-DIRECTED; NEOPLASMS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN KINASES; SERINE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033572093     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Barondes, S., Castronova, V., Cooper, D., Cummings, R., Drickamer, K., Feizi, T., Fitt, M. A., Hirbayashi, J., Hughes, C., Kasai, K., Leffler, H., Liu, F., Lotan, R., Mercurio, A. M., Monsigny, M., Pilllai, S., Poirer, F., Raz, A., Rigby, P., Rini, J. M., and Wang, J. L. Galectins: a family of animal β-galactoside-binding lectins. Cell, 76: 597-598, 1994.
2. Oda, Y., Leffler, H., Sakakura, Y., Kasai, K. I., and Barondes, S. H. Human breast carcinoma cDNA encoding a galactoside-binding lectin homologous to mouse Mac-2 antigen. Gene, 99: 279-283, 1991.
3. Raz, A., Pazerini, G., and Carmi, P. Identification of the metastasis-associated, galactoside-hinding lectin as a chimeric gene product with homology to an IgE-binding protein. Cancer Res., 49: 3489-3493, 1989.
4. Robertson, M. W., Albrandt, K., Keller, D. and Liu, F. T. Human IgE-binding protein: a soluble lectin exhibiting a highly conserved interspecies sequence and differential recognition of IgE glycoforms. Biochemistry, 29: 8093-8100, 1990.
5. Raz, A., Carmi, P., Raz, T., Hogan, V., Mohamed, A., and Wolman, S. R. Molecular cloning and chromosomal mapping of a human galactoside-binding protein. Cancer Res., 51: 2173-2178, 1991.
6. Yang, R-Y., Hill, P. N., Hsu, D. K., and Liu, F-T. Role of the carboxyl-terminal lectin domain in self-association of galectin-3. Biochemistry, 37: 4086-4092, 1998.
7. Inohara, H., and Raz, A. Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res., 55: 3267-3271, 1995.
8. Kuwabara, I., and Lui, F-T. Galectin-3 promotes adhesion of human neutrophils to laminin. J. Immunol., 156: 3939-3944, 1996.
9. Dagher, S. F., Wang, J. L., and Patterson, R. J. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc. Natl. Acad. Sci. USA, 92: 1213-1217, 1995.
10. Mehul, B., and Hughes R. C. J. Plasma membrane targeting, vesicular budding and release of galectin-3 from the cytoplasm of mammalian cells during secretion. J. Cell Sci., 110: 1169-1178, 1997.
11. Huflejt, M. E., Turck, C. W., Lindsted, R., Barondes, S. H., and Leffler H. L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. J. Biol. Chem., 268: 26712-26718, 1993.
12. Cowles, E. A., Agrwal, N., Anderson, R. L., and Wang, J. L. Carbohydrate-binding protein 35: isoelectric points of the polypeptide and a phosphorylated derivative. J. Biol. Chem., 265: 17706-17712, 1990.
13. Hamann, K. K., Cowles, E. A., Wang, J. L., and Anderson, R. L. Expression of carbohydrate binding protein 35 in human fibroblasts variations in the levels of mRNA, protein, and isoelectric species as a function of replicative competence. Exp. Cell Res., 196: 82-91, 1991.
14. Sanjuan, X., Fernandez, P. L., Castells, A., Castronova, V., Van den Brule, F., Liu, F. T., Casdesa, A., and Campo, E. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology, 113: 1906-1915, 1997.
15. Lotz, M. M., Andrews, C. M. Jr, Korzelius, C. A., Lee, E. C., Steele, G. D., Jr., Clarke, A., and Mercurio, A. M. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc. Natl. Acad. Sci. USA. 90: 3466-3470, 1993.
16. Lindsted, R., Apodaca, G., Barondes, S. H., Mostov K. E., and Leffler, H. Apical secretion of a cytosolic protein by Madin-Darby canine kidney cells. J. Biol. Chem., 268: 11750-11757, 1993.
17. Sato, S., Burgett, I., and Hughes, R. C. Secretion of the baby hamster kidney 30-kDa galactoside-binding lectin from polarized cells: a pathway independent of the endoplasmic reticulum-Golgi complex. Exp. Cell Res., 207: 8-18, 1993.
18. Sato, S., and Hughes, R. C. Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J. Biol. Chem., 269; 4424-4430, 1994.
19. Nangia-Makker, P., Thompson, E., Hogan, C., Ochieng, J., and Raz, A. Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell line. Int. J. Oncol., 7: 1079-1012, 1995.
20. De Bastelier, P., Katzau, S., Gorelik, E., Feldman, M., and Segal, S. Differential expression of H-2 gene products in tumor cells is associated with their metastagenic properties. Nature (Lond.), 288: 179-181, 1980.
21. Raz, A., Meromsky, L., and Lotan, R. Differential expression of endogenous lectins on the surface of nontumorigenic tumorigenic, and metastatic cells. Cancer Res., 46: 3667-3672, 1986.
22. Ogawa, H., Inouye, S., Tsuji, F. I., Yasuda, K., and Umesono, K. Localization, trafficking, and temperature-dependence of the aequorea green fluorescent protein in cultured vertebrate cells. Proc. Natl. Acad. Sci. USA, 92: 11899-11903, 1995.
23. Raz, A., and Lotan, R. Lectin-like activities associated with human and murine neoplastic cells. Cancer Res., 41: 3642-3647, 1981.
24. Ochieng, J., Platt, D., Tait, L., Hogan, V., Raz, T., Carmi, P., and Raz, A. Structure-function relationship of a recombinant human galactoside-binding protein. Biochemistry, 32: 4455-4460, 1993.
25. Wang, L., Inohara, H., Pienta, K. J., and Raz, A. Galectin-3 is a nuclear matrix protein which binds RNA. Biochem. Biophys. Res. Commun., 217: 292-303, 1995.
26. Herrmann, J., Turck, C. W., Atchison, R. E., Huflejt, M. E., Poulter, L., Gitt, M. A., and Leffler, H. Primary structure of the soluble lactose binding lectin L-29 from rat and dog and interaction of its non-collagenous praline-, glycine-, tyrosine-rich sequence with bacterial and tissue collagenase. J. Biol. Chem., 268: 26704-26711, 1993.
27. Massa, S. M., Cooper, D. N. W., Leffler, H., and Barondes, S. H. L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity. Biochemistry, 12: 260-267, 1993.
28. Cho, M., and Cummings, R. D. Characterization of monomeric forms of galectin-1 generated by site-directed mutagenesis. Biochemistry, 35: 13081-13087, 1996.